Table 2 Laboratory parameters of the patients with malignancy according to NRS scores

CBC

RBC (Million/µl)

4.07 ± 0.74

4.14 ± 0.71

3.80 ± 0.77

0.001

WBC (×10³/µl)

5.12 ± 1.79

5.12 ± 1.72

5.13 ± 2.02

0.97

Platelet (×10³/µl)

189.21 ± 67.16

189.88 ± 65.66

186.88 ± 72.67

0.75

Hgb (g/dL)

11.86 ± 1.92

12.00 ± 1.78

11.37 ± 2.30

0.05

Hct (%)

34.71 ± 5.45

35.11 ± 5.24

33.34 ± 5.98

0.02

Electrolyte status

Na (mEq/L)

142.07 ± 3.16

142.21 ± 3.15

141.58 ± 3.19

0.16

K (mEq/L)

4.13 ± 2.12

4.17 ± 2.40

4.00 ± 0.34

0.57

Ca (mg/dL)

9.55 ± 1.00

9.54 ± 1.08

9.61 ± 0.65

0.61

P (mg/dL)

3.94 ± 0.63

3.91 ± 0.59

4.01 ± 0.75

0.27

Mg (mEq/L)

1.93 ± 0.23

1.92 ± 0.23

1.98 ± 0.23

0.11

Liver function tests

ALT (U/L)

32.97 ± 17.68

32.89 ± 17.67

33.27 ± 17.86

0.88

AST (U/L)

26.79 ± 10.03

26.49 ± 9.38

27.83 ± 12.03

0.35

ALP (U/L)

208.55 ± 67.60

205.53 ± 67.81

219.06 ± 66.35

0.16

Bilirubin-T (mg/dL)

0.91 ± 1.73

0.95 ± 1.96

0.79 ± 0.31

0.54

Bilirubin-D (mg/dL)

0.30 ± 0.14

0.30 ± 0.14

0.31 ± 0.14

0.67

Renal function tests

BUN (mg/dL)

14.03 ± 4.11

14.18 ± 4.00

13.50 ± 4.48

0.26

Cr (mg/dL)

0.94 ± 0.17

0.95 ± 0.17

0.91 ± 0.14

0.13

Coagulation tests

PT

12.20 ± 0.90

12.14 ± 0.89

12.42 ± 0.91

0.03

PTT

31.02 ± 5.58

30.71 ± 5.47

32.09 ± 5.85

0.08

INR

1.10 ± 0.86

1.11 ± 0.98

1.03 ± 0.07

0.51